Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $9.7 million.

  • Angiodynamics' Prepaid Assets fell 2039.36% to $9.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $9.7 million, marking a year-over-year decrease of 2039.36%. This contributed to the annual value of $7.5 million for FY2025, which is 4190.89% down from last year.
  • As of Q4 2025, Angiodynamics' Prepaid Assets stood at $9.7 million, which was down 2039.36% from $13.0 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Prepaid Assets registered a high of $15.6 million during Q3 2022, and its lowest value of $4.6 million during Q2 2023.
  • Moreover, its 5-year median value for Prepaid Assets was $11.0 million (2021), whereas its average is $10.9 million.
  • In the last 5 years, Angiodynamics' Prepaid Assets plummeted by 5734.48% in 2023 and then soared by 18094.0% in 2024.
  • Over the past 5 years, Angiodynamics' Prepaid Assets (Quarter) stood at $11.5 million in 2021, then rose by 12.5% to $12.9 million in 2022, then crashed by 32.67% to $8.7 million in 2023, then surged by 39.93% to $12.2 million in 2024, then dropped by 20.39% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q4 2025, $13.0 million for Q3 2025, and $7.5 million during Q2 2025.